Gonorrhoea: drug resistance compromises recommended treatment in Europe

Gonorrhoea is the second most commonly notified sexually transmitted infection across the EU/EEA countries with almost 500 000 reported cases between 2007 and 2016. The infection is treatable but Neisseria gonorrhoeae keep showing high levels of azithromycin resistance according to latest results of the European Gonococcal Antimicrobial Surveillance Programme. This antibiotic agent is part of the currently recommended therapy regimen for gonorrhoea and observed resistance patterns threaten its effectiveness.

Article: ECDC